Efficacy and safety of S-1 following gemcitabine with cisplatin for advanced biliary tract cancer

Conclusions The efficacy and safety of S-1 following GC were almost the same as those of S-1 following GEM monotherapy for unresectable or recurrent BTC.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research